Singapore firm working on experimental cancer drugs plans listing by end-May
HONG KONG: A Singaporean biotechnology company working on experimental cancer drugs is listing in Taiwan, potentially opening the door for more foreign peers to go public on the island.
Already a subscriber? Log in.
Subscribe or renew your subscriptions to win prizes worth up to RM68,000!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!